ANDERA PARTNERS - Stock Holdings in 13F Filings (SEC)

Updated on March 15, 2026.

Based on 13F Filings filed with the SEC on February 17, 2026, for the 2025 Q4 period, ANDERA PARTNERS held in its portfolio 5 assets valued at $176,607,205 (i.e. $176.61M).

The most valuable assets in the portfolio included: KESTRA MED TECHNOLOGIES LTD ($67.36M), MINERALYS THERAPEUTICS INC ($57.77M), and EVOMMUNE INC ($32.48M).

The chart below shows the top 5 valuable assets, and the table below shows the top 5 valuable assets.

You can see similar for other investment managers.

Related Topics: SEC Topic List.

Data Source: SEC.

Top Valuable Stocks in ANDERA PARTNERS Portfolio

KESTRA MED TECHNOLOGIES LTD

MINERALYS THERAPEUTICS INC

EVOMMUNE INC

ABIVAX SA

INVENTIVA SA

ANDERA PARTNERS - Stock Holdings in 13F Filings (SEC)

Items per page:

0 of 0

Name of Issuer	No. of Shares	Value ($)	Class
KESTRA MED TECHNOLOGIES LTD	2540106	67363611	SHS
MINERALYS THERAPEUTICS INC	1591917	57770668	COM
EVOMMUNE INC	1897362	32482837	COM SHS
ABIVAX SA	78125	10535547	SPONSORED ADS
INVENTIVA SA	1818181	8454542	ADS